Integration of transcriptomic data reveals lipid metabolic heterogeneity and identifies GSTO1 as a therapeutic target in acute myeloid leukemia - Top-Institutions - MDSpire

Integration of transcriptomic data reveals lipid metabolic heterogeneity and identifies GSTO1 as a therapeutic target in acute myeloid leukemia

  • By

  • Fangmin Zhong

  • Zihao Wang

  • Jialin Huang

  • Linfeng Jin

  • Fangyi Yao

  • Xiaozhong Wang

  • June 30, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Hematology
    • Oncology

  • #2

    Saint Louis University Hospital
    Saint Louis University Hospital

    Saint Louis, Missouri

    Key Differentiators

    • Hematology

  • #3

    Lille University Hospital
    Lille University Hospital

    Lille, Hauts-de-France

    Key Differentiators

    • Hematology

  • #4

    Maisonneuve-Rosemont Hospital
    Maisonneuve-Rosemont Hospital

    Montreal, Quebec

    Key Differentiators

    • Hematology

  • #5

    Université de Montréal
    Université de Montréal

    Montreal, Quebec

    Key Differentiators

    • Hematology

Original Source(s)

Integration of transcriptomic data reveals lipid metabolic heterogeneity and identifies GSTO1 as a therapeutic target in acute myeloid leukemia

  • by Fangmin Zhong, Zihao Wang, Jialin Huang, Linfeng Jin, Fangyi Yao, Xiaozhong Wang

  • June 30, 2026

Related Content

BRCA1/2 variant landscape and clinical correlates in high-risk breast cancer patients from Eastern China

Case report: Beyond arrhythmia: STAR-inspired single-fraction cardiac radioablation for Ewing sarcoma metastasis

Long term survival of patients with alpha-fetoprotein-positive hepatoid adenocarcinoma of the gallbladder: a case report and literature review